flash-finance
CLSA sees nearly 60% upside in Ather Energy, initiating coverage with an “Outperform” rating and a Rs 1,450 target. The brokerage cites a “twin engine” of cost deflation and premiumisation, strong software-led revenues, and improving unit economics, expecting EBITDA breakeven by FY28 and significant
Wockhardt shares surged after the company received CDSCO approval for its breakthrough antibiotic Zaynich in India. Strong Phase 3 trial results and the drug’s potential to treat severe drug-resistant infections boosted investor sentiment, helping the stock extend recent gains despite technically en
Japan Economic Snapshot: Data beats estimates across retail, output, and jobs as Tokyo inflation cools
Asia FX, dollar tepid as traders weigh Iran peace prospects, soft Tokyo CPI
Japanese commodities major Mitsui is looking for investment opportunities in liquefied natural gas to secure the long-term supply of electricity for the booming data center industry. The company will be looking for either equity stake acquisitions or offtake agreements, the chief executive of Mitsui
Asian stocks climb as U.S.-Iran truce talks ease oil prices; tech shares surge
Supriya Lifescience shares jumped over 16% after the company posted a strong Q4FY26 performance, with PAT rising 47% YoY and revenue surging 50%. Robust demand across therapeutic segments, improved capacity utilisation, and traction in regulated markets supported growth. The stock remains in an uptr
Peabody prices $225M convertible debt offering
Foxconn to start shipping next-gen transmission tech for AI data centers
automated-news
The UK’s much-discussed relationship with the bond markets may be dysfunctional, but it isn’t particularly complicated. It boils down to one basic fact about humanity: Nobody thinks kindly of the people who lend them money.